Links between epilepsy and Alzheimer's disease (AD) are seen in both human 1 patients and mouse models. Human patients with AD may commonly have 2 subclinical epileptiform spikes (EP spikes) 1 , and overt epilepsy is associated with 3 more rapid cognitive decline 2 . Mechanistic studies in mouse models of 4 Alzheimer's disease (AD) have shown that altered network activity and 5 epileptiform spikes stem from dysfunctional inhibitory interneurons 3 , which are 6 key elements of cortical circuits underlying cognition 4 . Treatments that reduce 7 epileptiform spikes improve cognition in these models 5,6 . Thus, targeting 8 subclinical epileptiform activity may be a promising new therapeutic approach to 9 AD 7 . Ketogenic diet (KD) has long been used to treat forms of epilepsy 8 , including 10 Dravet syndrome, a childhood epilepsy caused by mutations in a gene that is 11 critical for inhibitory interneuron function in mouse AD models 5,9 . However, the 12 concurrent effects of a ketogenic diet on brain electrical activity, cognitive 13 decline, and survival have not been tested, and the translational rationale and 14 feasibility of such an intervention remain uncertain. Here we show that a 15 ketogenic diet reduces epileptiform spikes in the hAPPJ20 mouse model of AD. 16 Similar reduction of EP spikes is observed using a β-hydroxybutyrate (BHB) ester 17 in both AD and Dravet mice. A ketogenic diet improves context-dependent and 18 visuo-spatial learning in hAPPJ20 mice. It also reduces the high seizure-related 19 mortality observed in male mice of this model. Therapies derived from β-20 hydroxybutyrate may have potential application in ameliorating cognitive 21 dysfunction in AD through reducing subclinical epileptiform activity. 22
hAPPJ20 (APP) mice carry a human APP transgene with the Swedish and Indiana 1 familial AD-causing mutations (J20 line) 10 and display amyloid deposition, cognitive 2 deficits, spontaneous epileptiform spikes, and high early mortality 5, 11 . In order to test if a 3 ketogenic diet would suppress epileptiform spikes in hAPPJ20 mice, we designed a pair 4 of diets matched for protein content and micronutrients: normal high-carbohydrate 5 control diet based on AIN-93M (Control), and a zero-carbohydrate ketogenic diet (KD) 6 ( Fig. 1a) . In pilot experiments, we found that initiation of KD did not change caloric 7 intake ( Fig. 1b) , but resulted in a sustained increase of blood β-hydroxybutyrate (BHB) 8 levels similar to that of an overnight fast ( Fig. 1c) . We then followed a cohort of 9 hAPPJ20 mice undergoing serial 23-hour EEG recordings (EEGs) under three 10 conditions: on control diet, on the second day after starting KD, and during one day of 11 fasting (Fig. 1d ). Mice recovered on the control diet for 3 weeks between the KD and 12 fasting recordings. 13
14
We observed that KD, but not fasting, suppressed the rate of epileptiform spikes by 15 approximately 40% (Fig 1e and 1f ). Spike suppression was consistently observed 16 throughout the 23-hour recordings on KD (Figs. 1g) . Spike suppression was also 17 consistent between individual mice on KD, while fasting exacerbated spikes in some 18 mice ( Fig. 1h ). To further explore the kinetics of EP spike suppression, we obtained 19
EEGs with a separate cohort of mice that alternated from control diet to KD and back to 20 control over a period of 3 weeks (Fig. 1i ). Spikes were suppressed while on KD, but 21 rebounded to prior frequency immediately after returning to the control diet (Figs. 1j and 22 1k). We then followed two parallel cohorts of hAPPJ20 mice fed control diet of KD for 23 three months, with nine EEG sessions during the latter half of this period (Fig. 1l ). This 1 chronic feeding of KD suppressed EP spikes similarly to the earlier acute feedings (Figs 2 1m and 1n). 3 4 KD is a complex, pleiomorphic intervention with many potential mechanisms for 5 epileptiform spike suppression, including both energetic and signaling functions of BHB, 6 reduced insulin levels, provision of substrates for fatty acid oxidation, and many others 12 . 7 To test if BHB is the active component of KD in spike suppression, we developed a set 8 of novel small molecules consisting of six-or eight-carbon fatty acids ester-linked to 9 BHB ( Fig. 2a ). Compound C6-BHB increased plasma BHB levels the most after 10 intraperitoneal injection of equimolar amounts into mice fed a control diet ( Fig. 2b ) 11
without altering blood glucose (Extended Data Fig. 1a ). In a longitudinal, crossover 12 study, we injected both C6-BHB and saline intraperitoneally into a cohort of hAPPJ20 13 mice on separate days, and recorded 50-minute EEGs both before and after each 14 injection ( Fig. 2c ). Injection of C6-BHB reduced epileptiform spikes by 35% compared to 15 saline injection (Figs. 2d) consistent with the model that BHB induced by the ketogenic 16 diet is the key suppressor of EP spikes. 17
18
Epileptiform spikes in hAPPJ20 mice is caused by the loss of activity of GABAergic 19 interneurons which normally provide a consistent inhibitory tone and oscillatory network 20 activity (gamma activity, measured in the 30-90 Hz gamma frequency range on EEG), 21 thereby preventing pathological hyper synchronization of neuronal networks 13 . 22
Interneuron dysfunction in hAPPJ20 mice in turn is associated with loss of expression of 23 the sodium channel subunit Nav1.1 (encoded by Scn1a), and cognition is improved by 1 restoring Nav1.1 levels by Scn1a-BAC expression 5 . Interestingly, Dravet syndrome, a 2 childhood epilepsy caused by mutations in Scn1a, is often treated with a KD 9 , leading 3 us to ask whether the C6-BHB ester would also suppress EP spikes in this mouse 4 model. Indeed, C6-BHB suppressed EP spikes by 38% in Dravet mice (Figs. 2e) in 5 agreement with the shared mechanistic models between Dravet and hAPPJ20 mice. 6 7
In order to assess neuronal mechanisms of spike suppression by KD, we next analyzed 8 the relationships between exploratory movement, interneuron activity, and epileptiform 9 spikes during the 23-hour EEG recordings ( Fig. 1d ). Exploratory movement is 10 associated with increased interneuron-dependent gamma activity and suppression of 11 epileptiform spikes in hAPPJ20 5 . However, overall movement was similar in all three 12 conditions ( Fig. 3a) , indicating that spike suppression from KD was not an artifact of 13 effects on movement. Moreover, KD reduced spikes at all movement levels, including 14 when mice were at rest ( Fig. 3b ). Next we assessed whether presynaptic interneuron 15 activity (gamma) was affected by KD. KD did not increase the induction of gamma 16 power with increased movement (Fig. 3c ), and there was no difference in overall 17 movement-normalized gamma activity ( Fig. 3d ). Nor was there a change in the overall 18 fraction of EEG power in the gamma range ( Fig. 3e) . Instead, we observed that mice on 19 KD had fewer spikes at all levels of movement-adjusted gamma activity ( Fig. 3f ). Similar 20 analysis of the cohort of mice that alternated from control diet to KD and back to control 21 over a period of 3 weeks ( Fig. 1i ) revealed the same pattern (Extended Data Fig. 2a-c) . 22
Analysis of the BHB ester injection experiment (Fig. 2 ) similarly showed that the 23 strongest reduction in EP spikes during periods at rest, when saline-injected mice had 1 the most EP spikes (Extended Data Fig. 2d -g). Altogether, these data indicate that KD 2 suppresses epileptiform spikes in hAPPJ20 mice; spike suppression is recapitulated by 3 a BHB ester; and spike suppression via KD is not due to nonspecific effects on 4 exploratory activity but occurs either independently of inhibitory interneurons, or 5 downstream of the presynaptic potentials that generate gamma activity. 6 7 Finally, we investigated whether EP spike suppression by KD is associated with 8 improvements in memory or survival in hAPPJ20 mice. These mice display 9 characteristic deficits in context-dependent learning, which can be observed as a failure 10 to habituate to a novel environment. During a three-month study ( Fig. 1l ), mice were 11
exposed to the open field four times in the first month of treatment as training, followed field sessions, hAPPJ20 mice on the control diet exhibited hyperactivity and high levels 15
of exploratory movements, as measured by total movement, center movement and 16 rearings ( Fig. 4b-d ), demonstrating a lack of habituation that reflects impaired memory. 17
Wild-type (WT) mice showed strong habituation, with low exploratory movement in the 18 test open fields. Strikingly, hAPPJ20 mice on KD displayed habituation as strong as WT 19 mice, with reduced total movement (Fig. 4b ), and reduced exploratory movements such 20 as movements through the center of the open field ( Fig. 4c ) and rearings ( Fig. 4d) . 21
22
To further investigate the effect of KD on memory and survival, we undertook a larger, 1 6-month study, beginning with 2-month-old hAPPJ20 and WT mice ( Fig. 4e ). KD was 2 associated with significant weight gain in both genotypes ( Fig. 4f ). Six blood draws 3 obtained every ~2 weeks from the start of the study showed that KD was associated 4 with plasma BHB levels averaging ~1 mM over the 6-month period, ~10-fold higher than 5 controls ( Fig. 4g ). Blood glucose levels were similar in all groups (Fig. 4h ). KD was 6 associated with increased mean daily calorie intake over the 6 months (Extended Data 7 Fig. 3a ). Two separate studies of habituation to the open field again showed reduced 8 exploratory center movement and rearings for hAPPJ20 mice on KD in comparison to 9 the control diet, indicating enhanced context-dependent learning (Extended Data Fig.  10 3b-g). Importantly, analysis of the first open field gave no suggestion of an anxiolytic 11 effect of KD (Extended Data Fig. 4a-d) 14 . During Morris water maze testing, hAPPJ20 12 mice on KD showed significantly better performance in the hidden-platform training 13 (learning) trials of the water maze than hAPPJ20 mice on the control diet ( Fig. 4i ). This 14 improvement remained consistent when the location of the platform was moved during 15 reverse training ( Fig. 4j ). However, there was no difference in performance during the 16 probe (memory) trial of the water maze, either after initial hidden platform training or 17 after reverse training (Extended Data Fig. 5 ). There was no clear association between 18 performance in the water maze and either sex or mean plasma BHB levels (Extended 19 Data Fig. 6 ). hAPPJ20 mice exhibit substantial early mortality, particularly in males 5 that 20 may be to be due to fatal seizures. KD did not affect the relatively lower mortality among 21 females ( Fig. 4k ). Remarkably, however, the high early mortality among males was 22 strongly reduced ( Fig. 4l) . 23 8 1
In summary, we found that KD suppresses epileptiform spikes, improves context-2 dependent learning and visuo-spatial memory performance, and increases survival in 3 the hAPPJ20 mouse model of AD (Extended Data Fig. 7 ). Spike suppression can be 4 attained with a BHB-fatty acid ester compound on a normal diet, demonstrating that 5 BHB is an active anti-epileptogenic component of KD in this model. These data provide 6 a mechanistic understanding of earlier observations of visuo-spatial memory 7 improvement with KD 15 or a ketone ester diet 14 . The magnitude of spike suppression is 8 similar to that obtained by low doses of the antiepileptic drug levetiracetam 6 or by 9 transgenic expression of SCN1A in interneurons 5 . The specific mechanism of BHB is 10 likely multifactorial; although the immediacy of spike suppression excludes changes in 11
Aβ accumulation, other etiologies might include mitochondrial energetics 16 , modulation 12 of potassium channel activity 17 , deacetylase inhibition 18 , protein β-hydroxybutyrylation 19 , 13 or increased GABA synthesis 20 . Potentiation of GABA synthesis has been observed 14 with both BHB and KD 21 , and increased capacity for GABAergic neurons (such as the 15 gamma-generating inhibitory interneurons) to rapidly replenish GABA from glutamate is 16 one potential anti-epileptic mechanism of BHB that would fit our findings. While caution 17 is appropriate in considering complex dietary interventions for elderly patients with 18 dementia, compounds derived from BHB such as ketone esters 22 , as well as 19 recapitulation of the molecular mechanisms of BHB, hold promise as therapies for AD. 20
In addition, EEG monitoring of epileptiform activity could provide an important biomarker 21
for efficacy of such agents in clinical trials. Data were recorded during the 23 hour EEGs in Fig 1d. a, Movement was similar in all 2 conditions. b, Regression plot of per-minute EP spikes versus movement. hAPPJ20 3 mice on the control diet exhibited fewer spikes during higher exploratory movement. On 4 KD, spikes were lower at all movement levels. c, Regression plot of gamma activity 5 normalized to movement (1.0 at rest) versus movement showed no change in the rate 6 of induction of gamma activity by movement for KD or fasting. d, Hourly plot of 7 movement-normalized gamma activity was not different between diet conditions. e, The 8
proportion of overall EEG power in the gamma frequency range was unchanged by KD 9
or fasting. f, Regression plot of EP spikes versus movement-normalized gamma activity 10 showed fewer spikes on KD at all levels of normalized gamma. Fig. 1l (a, schematic) . During the test open fields, APP mice on KD showed normal 3 levels of movement (b), center movement (c), and rearings (d), indicating successful 4 learning. Data from the two open field sessions are pooled. e-l, 7-month study of KD in 5 hAPPJ20 mice (e, schematic). Mice gained weight on KD (f), showing persistently 6 elevated blood BHB (g) but normal blood glucose (h). KD improved visuo-spatial 7 learning performance for APP mice during both forward (i) and reverse (j) training in the 8
Morris water maze. KD did not affect survival of female hAPPJ20 mice (k) but markedly 9 improved male survival (l). Arrows show the start of study diets (45 days old). Mice were maintained in a barrier facility on a 7:00 am to 7:00 pm light cycle and had 8 free access to water. Except if stated otherwise, they were housed in littermate groups 9 of up to 5 mice per cage, and fed ad libitum a standard chow diet (5053 PicoLab 13% fat, and 62% carbohydrates. The ketogenic diet is of dough-like texture that 17 permits it to be placed in the food well of the cage-top wire lid, in the same manner as 18 pellets. All custom diets were changed weekly. 19 20
Mouse cohort descriptions 21
In all figures, "APP" is hAPPJ20; "WT" are wild-type littermates that do not carry the 22 hAPP transgene; "Con" or "con diet" is the control diet; "KD" is ketogenic diet. 23 Con n=26 (12M, 14F), WT KD n=23 (16M, 7F). For water maze, APP Con n=12 (3M, 6 9F), APP KD n=14 (5M, 10F), WT Con n=11 (6M, 5F), WT KD n=11 (6M, 5F). 7 8
Blood draws 9
Blood for plasma BHB testing was obtained via minimal distal tail snip, with mice placed 10 into a whole-body restrainer (Braintree Scientific) for comfort. ~40 µL whole blood was 11 drawn for a BHB assay, and collected into microvettes coated with Li-Heparin (Sarstedt). 12
Plasma was separated by centrifugation at 1500 x G for 15 min at 4 °C, and kept frozen 13 at -20 °C until use. 14 15
Blood assays 16
BHB concentrations were determined from plasma using a BHB enzymatic detection kit 17 (Stanbio Laboratory, Boerne, TX). Reactions were run with 3 uL of plasma each, in 18 triplicate. Background absorbance recorded before substrate addition was subtracted 19 form the final absorbance to correct for any hemolysis in the plasma samples. 20
Absorbance was compared to a standard curve. We validated that a standard curve 21 made using the kit-supplied standard (0-1 mM BHB) provided linear values up to 4 mM 22 by testing 1-10 mM BHB solutions prepared fresh from powder (Sigma 298360). Blood 23 glucose was evaluated on a drop of whole blood using a commercial glucometer 1 (FreeStyle Freedom Lite). 2 3 Electroencephalograms 4
Dravet and hAPPJ20 mice were implanted (under anesthesia) with Teflon-coated silver 5 wire electrodes (0.005-inch diameter) attached to a microminiature connector bilaterally 6 into the subdural space over frontal, central, parietal, and occipital cortices. For EEG 7 recordings, mice were placed into clear plastic containers that were either 50 cm 8 diameter cylinders (injection experiments) or 20x20 cm boxes (all other non-open-field 9 recordings). Mice are free to move around the container during recordings. For 23-hour 10 recordings, the container was lined with absorbent bedding and mice were provided 11 with food in a small glass jar and water via gel-pack. For other recordings, the floor of 12 the container was bare. Some EEGs were recorded during open-field experiments; this 13 apparatus is described below. All apparatuses were disinfected with Vimoba prior to use 14 and cleaned with 70% ethanol between mice. 15 16 EEG recording was performed with Harmonie software from Stellate Systems. Gotman 17 spike detectors from Harmonie were used to automatically detect epileptiform spikes, 18 which is defined by a peak lasting less than 80 ms and reaching an amplitude greater 19 than five-fold the average baseline amplitude measured during the 5 sec before the 20 spike 11,23 . 21 22
